Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01109069
Title Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pharmacyclics LLC.
Indications

B-cell lymphoma

Therapies

Ibrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.